TY - JOUR
T1 - A Review of Antithrombotic Agents in Dermatologic Surgery and Context for a Practical Approach, With Cardiology and Pharmacologic Input
AU - Rao, Elizabeth
AU - Andrasik, Wyatt
AU - Michalski, Basia M.
AU - Tarakji, Khaldoun G.
AU - Militello, Michael A.
AU - Lucas, Jennifer L.
N1 - Publisher Copyright:
Copyright © 2023.
PY - 2023/5
Y1 - 2023/5
N2 - Dermatologic surgeons are encountering more patients on antithrombotic agents. There are no established consensus guidelines for managing antithrombotic agents in the perioperative period. We provide an updated overview of antithrombotic agents in dermatologic surgery and management of such agents in the perioperative period with additional unique perspectives from cardiology and pharmacy. A literature search of PubMed and Google Scholar was performed to review the English-language medical literature. The landscape of antithrombotic therapy is changing with a notable rise in the use of direct oral anticoagulants (DOACs.) While no consensus guidelines exist, most studies recommend continuing antithromboticDo therapy NotinCopy the perioperative period with appropriate lab monitoring, when applicable. However, recent data suggest it is safe to hold Penalties DOACs in Apply the perioperative period. As antithrombotic therapy evolves, the dermatologic surgeon needs to remain current with the most recent available data. Where data are limited, a multidisciplinary approach to managing these agents in the perioperative period is essential.
AB - Dermatologic surgeons are encountering more patients on antithrombotic agents. There are no established consensus guidelines for managing antithrombotic agents in the perioperative period. We provide an updated overview of antithrombotic agents in dermatologic surgery and management of such agents in the perioperative period with additional unique perspectives from cardiology and pharmacy. A literature search of PubMed and Google Scholar was performed to review the English-language medical literature. The landscape of antithrombotic therapy is changing with a notable rise in the use of direct oral anticoagulants (DOACs.) While no consensus guidelines exist, most studies recommend continuing antithromboticDo therapy NotinCopy the perioperative period with appropriate lab monitoring, when applicable. However, recent data suggest it is safe to hold Penalties DOACs in Apply the perioperative period. As antithrombotic therapy evolves, the dermatologic surgeon needs to remain current with the most recent available data. Where data are limited, a multidisciplinary approach to managing these agents in the perioperative period is essential.
UR - http://www.scopus.com/inward/record.url?scp=85159548219&partnerID=8YFLogxK
U2 - 10.36849/JDD.7456
DO - 10.36849/JDD.7456
M3 - Article
C2 - 37133483
AN - SCOPUS:85159548219
SN - 1545-9616
VL - 22
SP - 496
EP - 501
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
IS - 5
ER -